Atomistry » Magnesium » PDB 5v60-5voi » 5vof
Atomistry »
  Magnesium »
    PDB 5v60-5voi »
      5vof »

Magnesium in PDB 5vof: Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

Enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

All present enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban:
3.4.21.6;

Protein crystallography data

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof was solved by S.Krishnaswamy, S.Kumar, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.05 / 2.25
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 55.744, 164.275, 124.521, 90.00, 90.00, 90.00
R / Rfree (%) 22 / 25.3

Other elements in 5vof:

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban also contains other interesting chemical elements:

Fluorine (F) 19 atoms
Calcium (Ca) 1 atom
Chlorine (Cl) 1 atom
Sodium (Na) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban (pdb code 5vof). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof:
Jump to Magnesium binding site number: 1; 2;

Magnesium binding site 1 out of 2 in 5vof

Go back to Magnesium Binding Sites List in 5vof
Magnesium binding site 1 out of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg101

b:43.2
occ:1.00
O1P A:CFL22 1.7 79.7 1.0
O A:HOH202 1.9 49.5 1.0
O A:HOH207 2.0 68.0 1.0
OP2 A:UFT23 2.2 92.2 1.0
O A:HOH203 2.2 45.0 1.0
OP1 A:A10 2.8 63.6 1.0
P A:CFL22 3.1 75.7 1.0
P A:UFT23 3.6 86.0 1.0
P A:A10 3.9 68.7 1.0
O2P A:CFL22 4.0 78.9 1.0
O5' A:CFL22 4.0 82.6 1.0
O3' A:A21 4.2 79.3 1.0
OP2 A:A10 4.2 64.2 1.0
C5' A:CFL22 4.3 85.9 1.0
O3' A:CFL22 4.3 89.4 1.0
C3' A:CFL22 4.3 89.0 1.0
O5' A:UFT23 4.5 84.8 1.0
O5' A:A10 4.6 68.3 1.0
O2P A:CFL9 4.6 76.4 1.0
OP1 A:UFT23 4.6 91.0 1.0
O3' A:CFL9 4.8 78.5 1.0
C5' A:A10 4.8 64.5 1.0
O6 A:G25 4.8 0.3 1.0
C5 A:UFT23 4.8 82.4 1.0
C4' A:CFL22 4.9 90.3 1.0

Magnesium binding site 2 out of 2 in 5vof

Go back to Magnesium Binding Sites List in 5vof
Magnesium binding site 2 out of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg102

b:50.5
occ:1.00
OP2 A:A10 1.5 64.2 1.0
O A:HOH212 1.9 45.2 1.0
O A:HOH208 2.4 42.4 1.0
O4 A:UFT24 2.4 74.5 1.0
P A:A10 2.7 68.7 1.0
O5' A:A10 3.2 68.3 1.0
N1 A:G25 3.6 92.4 1.0
C4 A:UFT24 3.6 78.8 1.0
N2 A:G25 3.7 0.6 1.0
F A:CFL9 3.9 93.0 1.0
O4 A:UFT23 3.9 82.0 1.0
O3' A:CFL9 4.0 78.5 1.0
OP1 A:A10 4.0 63.6 1.0
O A:HOH203 4.0 45.0 1.0
C2 A:G25 4.1 95.5 1.0
N3 A:UFT24 4.4 79.1 1.0
OP2 A:G11 4.5 69.2 1.0
C3' A:CFL9 4.5 74.9 1.0
C6 A:G25 4.5 84.5 1.0
C5 A:UFT24 4.6 79.4 1.0
C5' A:A10 4.6 64.5 1.0
O A:HOH207 4.6 68.0 1.0
O6 A:G25 4.6 0.3 1.0
O6 A:G13 4.7 71.5 1.0
C2' A:CFL9 4.7 70.9 1.0
C4 A:UFT23 4.8 83.1 1.0
C5 A:UFT23 5.0 82.4 1.0

Reference:

R.Gunaratne, S.Kumar, J.W.Frederiksen, S.Stayrook, J.L.Lohrmann, K.Perry, K.M.Bompiani, C.V.Chabata, N.K.Thalji, M.D.Ho, G.Arepally, R.M.Camire, S.Krishnaswamy, B.A.Sullenger. Combination of Aptamer and Drug For Reversible Anticoagulation in Cardiopulmonary Bypass. Nat. Biotechnol. V. 36 606 2018.
ISSN: ISSN 1546-1696
PubMed: 29863725
DOI: 10.1038/NBT.4153
Page generated: Mon Sep 30 06:11:50 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy